Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGSF9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TYMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KIF1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PUS7L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSHB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHGC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929475 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930404 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ULK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTNB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELOVL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERCC6L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on